series-a
Stage
2020
Founded
2
Investors
About
Antares Therapeutics is a biotechnology company developing first-in-class precision medicines targeting previously undruggable cancer and serious disease targets. The company leverages an integrated drug discovery platform combining advanced computational chemistry, predictive sciences, and experimental biology to develop transformative therapies.
Explore Antares Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.